Your browser doesn't support javascript.
loading
Polycystic liver diseases: from molecular basis to development of effective treatments.
Markaide, Enara; Bañales, Jesús M; Rodrigues, Pedro M.
Afiliación
  • Markaide E; Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute.
  • Bañales JM; Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute. CIBERehd. ISCIII. Ikerbasque. Universidad de Navarra.
  • Rodrigues PM; Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute. CIBERehd. ISCIII. Ikerbasque, Spain.
Rev Esp Enferm Dig ; 115(10): 542-545, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37114427
ABSTRACT
Polycystic liver diseases (PLDs) comprise a heterogeneous group of congenital genetic disorders that mainly affect bile duct epithelial cells, known as cholangiocytes. Patients with PLD usually present bile duct dilatation and/or progressive develop intrahepatic, fluid-filled biliary cysts (more than 10), which is the main cause of morbidity.

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Rev Esp Enferm Dig Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Rev Esp Enferm Dig Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article